ABSTRACT
In recent years, it has become clear that transsexualism and other forms of gender variance are not mental disorders, but conditions that need to be treated with state-of-the-art hormonal and surgical therapy to obtain reassignment to the desired gender (T’Sjoen et al. 2004) (Standards of Care, Levine et al. 1998; Meyer et al. 2001). Because of the effects of treatment on fertility, transition to the desired gender and reproduction appear to be mutually exclusive for transpeople. Therefore, loss of reproductive potential seems to be the “price to pay” for transition.
